Ravi Kumar Paluri, MD, MPH
- Associate Professor, Hematology and Oncology
Ravi Kumar Paluri, MD, MPH
- Education
- MBBS, Kakatiya Medical College, 2007
- Residency
- Internal Medicine, University of Alabama at Birmingham, 2012
- Fellowship
- Hematology / Oncology, University of Alabama at Birmingham, 2015
- Board Certifications
- American Board of Internal Medicine, Hematology
- American Board of Internal Medicine, Internal Medicine
- American Board of Internal Medicine, Medical Oncology
- Positions
- Associate Professor, Hematology and Oncology
- Departments and Affiliations
- Hematology and Oncology
- Comprehensive Cancer Center
Research
- Predictive Value of MUC5AC Signature in Pancreatic Ductal Adenocarcinoma: A Hypothesis Based on Preclinical Evidence. Manne A, Kasi A, Esnakula AK, Paluri RK. Int J Mol Sci. 2023 Apr; 24(9)
- Impact of the COVID-19 Pandemic on Management of Patients with Metastatic Pancreatic Ductal Adenocarcinoma in the United States. Paluri R, Laursen A, Gaeta J, Wang S, Surinach A, Cockrum P. Oncologist. 2022 Jun; 27(6):e518-e523.
- Use of Single-Item Self-Rated Health Measure to Identify Frailty and Geriatric Assessment-Identified Impairments Among Older Adults with Cancer. Giri S, Mir N, Al-Obaidi M, Clark D, Kenzik KM, McDonald A, Young-Smith C, Paluri R, Nandagopal L, Gbolahan O, Nyrop KA, Muss HB, Pergolotti M, Bhatia S, Williams GR. Oncologist. 2022 Feb; 27(1):e45-e52.
- Metastatic Alveolar Rhabdomyosarcoma with Extensive Bone Marrow Replacement in an Older Adult. Cheng JJ, Mott RT, Savage PD, Paluri RK. Case Rep Oncol. 2021; 14(3):1505-1510.
- Phase II clinical trial of one dose of post-transplant cyclophosphamide for graft versus host disease prevention following myeloablative, peripheral blood stem cell, matched-unrelated donor transplantation. Jamy O, Innis-Shelton R, Bal S, Paluri R, Salzman D, Di Stasi A, Costa L, Meredith R, Lamb L, Minagawa K, Mineishi S, Saad A. Am J Hematol. 2021 Oct; 96(10):E396-E398.